FDA approves generic version of Merck's Elestat ophthalmic solution
ALLEGAN, Mich. — The Food and Drug Administration has approved a drug made by Perrigo and PharmaForce/Luitpold Pharmaceuticals for treating eye allergies, Perrigo said.
The FDA approved epinastine hydrochloride ophthalmic solution in the 0.05% strength. The drug is a generic version of Merck's Elestat, used to treat ocular itching related to allergic conjunctivitis.
Annual sales for the branded version before the appearance of generics on the market were $30 million, according to Wolters Kluwer.